BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Prognosis
21 results:

  • 1. Expression of EGFR, PD-L1, and the mismatch repair proteins before and following therapy in malignant serous effusions with metastatic high-grade serous tubo-ovarian carcinoma.
    Nikas IP; Park SY; Song MJ; Lee C; Ryu HS
    Diagn Cytopathol; 2024 Feb; 52(2):69-75. PubMed ID: 37937321
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. DAXX, ATRX, and MSI in PanNET and Their Metastases: Correlation with Histopathological Data and prognosis.
    Gisder DM; Overheu O; Keller J; Nöpel-Dünnebacke S; Uhl W; Reinacher-Schick A; Tannapfel A; Tischoff I
    Pathobiology; 2023; 90(2):71-80. PubMed ID: 35691289
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The clinical features and management of Lynch syndrome-associated ovarian cancer.
    Ran X; Jing H; Li Z
    J Obstet Gynaecol Res; 2022 Jul; 48(7):1538-1545. PubMed ID: 35478369
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cathepsin F genetic mutation is associated with familial papillary thyroid cancer.
    Wang Y; Mei J; Zhang Y; He X; Zheng X; Tan J; Jia Q; Li N; Li D; Wang Y; Meng Z
    Am J Med Sci; 2022 Oct; 364(4):414-424. PubMed ID: 35447134
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Correlation of mismatch repair deficiency with clinicopathological features and programmed death-ligand 1 expression in thyroid carcinoma.
    Qiao PP; Tian KS; Han LT; Ma B; Shen CK; Zhao RY; Zhang Y; Wei WJ; Chen XP
    Endocrine; 2022 Jun; 76(3):660-670. PubMed ID: 35366156
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
    Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
    Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: study of 13 cases comparing ductal pancreatic carcinoma and review of the literature.
    Hrudka J; Lawrie K; Waldauf P; Ciprová V; Moravcová J; Matěj R
    Virchows Arch; 2020 Nov; 477(5):687-696. PubMed ID: 32424767
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinicopathological and survival characteristic of mismatch repair status in ovarian clear cell carcinoma.
    Zhu J; Ke G; Bi R; Wu X
    J Surg Oncol; 2020 Sep; 122(3):538-546. PubMed ID: 32396667
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma.
    Ahmad-Nielsen SA; Bruun Nielsen MF; Mortensen MB; Detlefsen S
    Pathol Res Pract; 2020 Jun; 216(6):152985. PubMed ID: 32360245
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immunohistological evaluation of mismatch repair deficiency in pancreatic ductal adenocarcinoma treated with surgical resection.
    Otsuka H; Murakami Y; Uemura K; Kondo N; Nakagawa N; Okada K; Seo S; Takahashi S
    J Hepatobiliary Pancreat Sci; 2020 Jul; 27(7):421-428. PubMed ID: 32219999
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma.
    Schmoeckel E; Hofmann S; Fromberger D; Rottmann M; Luthardt B; Burges A; Jeschke U; Kirchner T; Lax SF; Mayr D
    Virchows Arch; 2019 May; 474(5):599-608. PubMed ID: 30734108
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy.
    Zhao C; Li S; Zhao M; Zhu H; Zhu X
    Arch Gynecol Obstet; 2018 Jan; 297(1):153-159. PubMed ID: 29063235
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction.
    Jones MR; Kamara D; Karlan BY; Pharoah PDP; Gayther SA
    Gynecol Oncol; 2017 Dec; 147(3):705-713. PubMed ID: 29054568
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.
    Parra-Herran C; Lerner-Ellis J; Xu B; Khalouei S; Bassiouny D; Cesari M; Ismiil N; Nofech-Mozes S
    Mod Pathol; 2017 Dec; 30(12):1748-1759. PubMed ID: 28776572
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Synchronous Endometrial and Ovarian cancer in Young Women: Case Report and Review of the Literature.
    Dogan A; Schultheis B; Rezniczek GA; Hilal Z; Cetin C; Häusler G; Tempfer CB
    Anticancer Res; 2017 Mar; 37(3):969-978. PubMed ID: 28314254
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Long-term survival of patients with mismatch repair protein-deficient, high-stage ovarian clear cell carcinoma.
    Stewart CJ; Bowtell DD; Doherty DA; Leung YC
    Histopathology; 2017 Jan; 70(2):309-313. PubMed ID: 27442838
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Familial Adrenocortical Carcinoma in Association With Lynch Syndrome.
    Challis BG; Kandasamy N; Powlson AS; Koulouri O; Annamalai AK; Happerfield L; Marker AJ; Arends MJ; Nik-Zainal S; Gurnell M
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2269-72. PubMed ID: 27144940
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Multivariate analysis of immunohistochemical evaluation of protein expression in pancreatic ductal adenocarcinoma reveals prognostic significance for persistent Smad4 expression only.
    Ottenhof NA; Morsink FH; Ten Kate F; van Noorden CJ; Offerhaus GJ
    Cell Oncol (Dordr); 2012 Apr; 35(2):119-26. PubMed ID: 22351431
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds.
    Grindedal EM; Renkonen-Sinisalo L; Vasen H; Evans G; Sala P; Blanco I; Gronwald J; Apold J; Eccles DM; Sánchez AA; Sampson J; Järvinen HJ; Bertario L; Crawford GC; Stormorken AT; Maehle L; Moller P
    J Med Genet; 2010 Feb; 47(2):99-102. PubMed ID: 19635727
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Analysis of factors influencing recurrence and metastasis following curative resection of pancreatic ductal adenocarcinoma].
    Xie YB; Zhao P; Wang CF; Shan Y; Zhao DB; Liu Q; Bai XF
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):686-9. PubMed ID: 19173911
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.